Loading Shopping Cart Items...
This webinar, hosted by Dr. Natesa G. Pandian and Dr. Jin K. Kim, focuses on the new ASE Guideline entitled: Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease. This document provides recommendations for the comprehensive use of echocardiography in the diagnosis and therapeutic intervention of RHD. Echocardiographic diagnosis of RHD is made when typical findings of valvular and subvalvular abnormalities are seen, including commissural fusion, leaflet thickening, and restricted leaflet mobility, with varying degrees of calcification.
CME/MOC Information: 1.00 AMA PRA Category 1 Credit(s)™
Release Date: March 27, 2023
Expiration Date: March 27, 2026
Claim Credit By: March 27, 2026
Speakers:
Learning Objectives:
Disclosure:
ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.
While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)
The following faculty members have no relevant financial relationships with ineligible companies:
All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:
Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies. Click here for a list of these members.
None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies. Click here for a list of ASE staff members.